IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

TLR10 and Its Unique Anti-Inflammatory Properties and Potential Use as a Target in Therapeutics

  • Faith Fore (Department of Immunology, Postgraduate School, Universitas Airlangga) ;
  • Cut Indriputri (Department of Immunology, Postgraduate School, Universitas Airlangga) ;
  • Janet Mamutse (Department of Animal Breeding and Genetics, Faculty of Animal Science, University of Jenderal Soedirman) ;
  • Jusak Nugraha (Postgraduate School, Universitas Airlangga)
  • Received : 2020.02.04
  • Accepted : 2020.04.01
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

TLRs are pattern recognition receptors (PRRs) whose cytoplasmic signalling domain is similar to that of IL-1. The extracellular domain of TLRs serve as the binding site of pathogen associated molecular patterns. TLRs are found on both plasma and endosomal membranes and they mainly exert their function by activating genes which lead to production of inflammatory factors. The latest TLR to be discovered, TLR10 is a unique TLR which exhibit anti-inflammatory properties. TLR10 is found on the plasma membrane with other TLRs namely TLR1, TLR2, TLR4, TLR5 and TLR6. Studies have revealed that TLR10 is found on the same gene cluster with TLR1 and TLR6 and is also a coreceptor of TLR2. Up to date, TLR10 is the only TLR which exhibit anti-inflammatory property. Previously, TLR10 was thought to be an "orphan receptor" but much recent studies have identified ligands for TLR10. Currently there is no review article on TLR10 that has been published. In this narrative review, we are going to give an account of TLR10, its functions mainly as an anti-inflammatory PRR and its possible applications as a target in therapeutics.

Keywords

References

  1. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16-34. https://doi.org/10.3109/08830185.2010.529976
  2. Moresco EM, LaVine D, Beutler B. Toll-like receptors. Curr Biol 2011;21:R488-R493. https://doi.org/10.1016/j.cub.2011.05.039
  3. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511. https://doi.org/10.1038/nri1391
  4. Akira S. Toll-like receptor signaling. J Biol Chem 2003;278:38105-38108. https://doi.org/10.1074/jbc.R300028200
  5. Nie L, Cai SY, Shao JZ, Chen J, Chen J. Toll-like receptors, associated biological roles, and signaling networks in non-mammals. Front Immunol 2018;9:1523.
  6. Vidya MK, Kumar VG, Sejian V, Bagath M, Krishnan G, Bhatta R. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals. Int Rev Immunol 2018;37:20-36. https://doi.org/10.1080/08830185.2017.1380200
  7. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol 2014;5:461.
  8. Jimenez-Dalmaroni MJ, Gerswhin ME, Adamopoulos IE. The critical role of toll-like receptors--from microbial recognition to autoimmunity: a comprehensive review. Autoimmun Rev 2016;15:1-8. https://doi.org/10.1016/j.autrev.2015.08.009
  9. Kang JY, Lee JO. Structural biology of the toll-like receptor family. Annu Rev Biochem 2011;80:917-941. https://doi.org/10.1146/annurev-biochem-052909-141507
  10. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14. https://doi.org/10.1093/intimm/dxh186
  11. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010;32:305-315. https://doi.org/10.1016/j.immuni.2010.03.012
  12. Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR. Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population. Hum Immunol 2012;73:416-420. https://doi.org/10.1016/j.humimm.2012.01.015
  13. Lim KH, Staudt LM. Toll-like receptor signaling. Cold Spring Harb Perspect Biol 2013;5:a011247.
  14. Henrick BM, Yao XD, Zahoor MA, Abimiku A, Osawe S, Rosenthal KL. TLR10 senses HIV-1 proteins and significantly enhances HIV-1 infection. Front Immunol 2019;10:482.
  15. Oosting M, Cheng SC, Bolscher JM, Vestering-Stenger R, Plantinga TS, Verschueren IC, Arts P, Garritsen A, van Eenennaam H, Sturm P, et al. Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc Natl Acad Sci U S A 2014;111:E4478-E4484. https://doi.org/10.1073/pnas.1410293111
  16. Torices S, Julia A, Munoz P, Varela I, Balsa A, Marsal S, Fernandez-Nebro A, Blanco F, Lopez-Hoyos M, Martinez-Taboada V, et al. A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis. Arthritis Res Ther 2016;18:221.
  17. Verma R, Jung JH, Kim JY. 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1. J Steroid Biochem Mol Biol 2014;141:1-6. https://doi.org/10.1016/j.jsbmb.2013.12.012
  18. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, Guiet C, Briere F, Vlach J, Lebecque S, et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005;174:2942-2950. https://doi.org/10.4049/jimmunol.174.5.2942
  19. Xiao W, Liu Z, Lin J, Li J, Wu K, Ma Y, Gong Y, Liu Z. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease. Autoimmunity 2015;48:13-18. https://doi.org/10.3109/08916934.2014.939269
  20. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001;1518:157-161. https://doi.org/10.1016/S0167-4781(00)00289-X
  21. Tarlinton RE, Alder L, Moreton J, Maboni G, Emes RD, Totemeyer S. RNA expression of TLR10 in normal equine tissues. BMC Res Notes 2016;9:353.
  22. Shinkai H, Muneta Y, Suzuki K, Eguchi-Ogawa T, Awata T, Uenishi H. Porcine toll-like receptor 1, 6, and 10 genes: complete sequencing of genomic region and expression analysis. Mol Immunol 2006;43:1474-1480. https://doi.org/10.1016/j.molimm.2005.09.006
  23. Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, Matsushima K, Ohta K, Yamamoto K, Hirai K. Expression and function of toll-like receptors in eosinophils: activation by toll-like receptor 7 ligand. J Immunol 2003;171:3977-3982. https://doi.org/10.4049/jimmunol.171.8.3977
  24. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003;102:956-963. https://doi.org/10.1182/blood-2002-11-3355
  25. Park HJ, Hahn WH, Suh JS, Kim MJ, Kang SW, Lee JS, Kim JW, Chung JH, Cho BS. Association between toll-like receptor 10 (TLR10) gene polymorphisms and childhood IgA nephropathy. Eur J Pediatr 2011;170:503-509. https://doi.org/10.1007/s00431-010-1325-1
  26. Bell MP, Svingen PA, Rahman MK, Xiong Y, Faubion WA Jr. FOXP3 regulates TLR10 expression in human T regulatory cells. J Immunol 2007;179:1893-1900. https://doi.org/10.4049/jimmunol.179.3.1893
  27. Kim D, Kim YJ, Koh HS, Jang TY, Park HE, Kim JY. Reactive oxygen species enhance TLR10 expression in the human monocytic cell line THP-1. Int J Mol Sci 2010;11:3769-3782. https://doi.org/10.3390/ijms11103769
  28. Sindhu S, Akhter N, Kochumon S, Thomas R, Wilson A, Shenouda S, Tuomilehto J, Ahmad R. Increased expression of the innate immune receptor TLR10 in obesity and type-2 diabetes: association with ROS-mediated oxidative stress. Cell Physiol Biochem 2018;45:572-590. https://doi.org/10.1159/000487034
  29. Mourits VP, Arts RJW, Novakovic B, Matzaraki V, de Bree LCJ, Koeken VACM, Moorlag SJCFM, van Puffelen JH, Groh L, van der Heijden CDCC, et al. The role of Toll-like receptor 10 in modulation of trained immunity. Immunology 2020;159:289-297. https://doi.org/10.1111/imm.13145
  30. Hess NJ, Felicelli C, Grage J, Tapping RI. TLR10 suppresses the activation and differentiation of monocytes with effects on DC-mediated adaptive immune responses. J Leukoc Biol 2017;101:1245-1252. https://doi.org/10.1189/jlb.3A1116-492R
  31. Jimenez-Sousa MA, Martinez I, Medrano LM, Fernandez-Rodriguez A, Resino S. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol 2018;9:458.
  32. Verma R, Kim JY. 1,25-Dihydroxyvitamin D3 facilitates M2 polarization and upregulates TLR10 expression on human microglial cells. Neuroimmunomodulation 2016;23:75-80. https://doi.org/10.1159/000444300
  33. Pachathundikandi SK, Backert S. Differential expression of interleukin 1β during Helicobacter pylori infection of toll-like receptor 2 (TLR2)- and TLR10-expressing HEK293 cell lines. J Infect Dis 2016;214:166-167. https://doi.org/10.1093/infdis/jiw154
  34. Zhang Y, Cao R, Ying H, Du J, Chen S, Wang N, Shen B. Increased expression of TLR10 in B cell subsets correlates with disease activity in rheumatoid arthritis. Mediators Inflamm 2018;2018:9372436.
  35. Nagashima H, Iwatani S, Cruz M, Jimenez Abreu JA, Uchida T, Mahachai V, Vilaichone RK, Graham DY, Yamaoka Y. Toll-like receptor 10 in Helicobacter pylori infection. J Infect Dis 2015;212:1666-1676. https://doi.org/10.1093/infdis/jiv270
  36. Regan T, Nally K, Carmody R, Houston A, Shanahan F, Macsharry J, Brint E. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol 2013;191:6084-6092. https://doi.org/10.4049/jimmunol.1203245
  37. Tang H, Cheng Z, Ma W, Liu Y, Tong Z, Sun R, Liu H. TLR10 and NFKBIA contributed to the risk of hip osteoarthritis: systematic evaluation based on Han Chinese population. Sci Rep 2018;8:10243.
  38. Abad C, Gonzalez-Escribano MF, Diaz-Gallo LM, Lucena-Soto JM, Marquez JL, Leo E, Crivell C, Gomez-Garcia M, Martin J, Nunez-Roldan A, et al. Association of toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2. Genes Immun 2011;12:635-642. https://doi.org/10.1038/gene.2011.41
  39. Smith NL, Hankinson J, Simpson A, Denning DW, Bowyer P. Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT. Clin Microbiol Infect 2014;20:O960-O968. https://doi.org/10.1111/1469-0691.12643
  40. Ravishankar Ram M, Goh KL, Leow AH, Poh BH, Loke MF, Harrison R, Shankar EM, Vadivelu J. Polymorphisms at locus 4p14 of toll-like receptors TLR-1 and TLR-10 confer susceptibility to gastric carcinoma in Helicobacter pylori infection. PLoS One 2015;10:e0141865.
  41. Li M, Han W, Zhu L, Jiang J, Qu W, Zhang L, Jia L, Zhou Q. IRAK2 and TLR10 confer risk of Hashimoto's disease: a genetic association study based on the Han Chinese population. J Hum Genet 2019;64:617-623. https://doi.org/10.1038/s10038-019-0613-5
  42. Kim SK, Park HJ, Hong IK, Chung JH, Eun YG. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population. Endocrine 2013;43:161-169. https://doi.org/10.1007/s12020-012-9783-z
  43. Purdue MP, Lan Q, Wang SS, Kricker A, Menashe I, Zheng TZ, Hartge P, Grulich AE, Zhang Y, Morton LM, et al. A pooled investigation of toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 2009;30:275-281. https://doi.org/10.1093/carcin/bgn262
  44. Stevens VL, Hsing AW, Talbot JT, Zheng SL, Sun J, Chen J, Thun MJ, Xu J, Calle EE, Rodriguez C. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer 2008;123:2644-2650. https://doi.org/10.1002/ijc.23826
  45. Kizildag S, Arslan S, Ozbilum N, Engin A, Bakir M. Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease. J Med Virol 2018;90:19-25. https://doi.org/10.1002/jmv.24924
  46. Tongtawee T, Bartpho T, Kaewpitoon S, Kaewpitoon N, Dechsukhum C, Leeanansaksiri W, Loyd RA, Talabnin K, Matrakool L, Panpimanmas S. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand. Eur J Cancer Prev 2018;27:118-123. https://doi.org/10.1097/CEJ.0000000000000347
  47. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, Musser JM. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2007;2:e1318.
  48. Zhou XX, Jia WH, Shen GP, Qin HD, Yu XJ, Chen LZ, Feng QS, Shugart YY, Zeng YX. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk. Cancer Epidemiol Biomarkers Prev 2006;15:862-866. https://doi.org/10.1158/1055-9965.EPI-05-0874
  49. Boutens L, Mirea AM, van den Munckhof I, Doppenberg-Oosting M, Jaeger M, Hijmans A, Netea MG, Joosten LAB, Stienstra R. A role for TLR10 in obesity and adipose tissue morphology. Cytokine 2018;108:205-212. https://doi.org/10.1016/j.cyto.2018.03.021